The drug manufacturer Biofarm registered a net profit of 69.9 million RON in the first nine months of the year, up 6% compared to the same period last year, according to a company statement.The turnover increased by 10%, reaching 229 million RON, compared to 209 million RON in 2022. EBITDa reached 81.6 million RON during the mentioned period.In the first nine months of 2023, Biofarm occupied the 2nd place in the CHC (Consumer Healthcare) segment, in terms of the number of units sold. In terms of value, the company consolidated its sales to the final consumer, recording an increase of over 15% compared to the first nine months of 2022, compared to the purchase price in pharmacies.according to the source, the therapeutic areas with the greatest absolute increase in value in the first nine months of the year, in which Biofarm is active, were cold & flu, pain, magnesium-based supplements, digestion and nasal decongestants. The Biofarm brands associated with these therapeutic areas registered increases in their stock market share."The continuous development of new products, constantly adapted to the constantly diversifying consumer needs, represents one of the growth pillars of the Biofarm company. The company is also the volume market leader in the reference categories of eight of its brands: Bixtonim, Colebil, Triferment, Sennalax, Extravalerianic, Carmol solution, Carbocit and Nervocalmin. This balanced mix between long-lived brands and innovation is a strong differentiator for the Biofarm portfolio, positioning the company among the most relevant players in the CHC category," the release states.Biofarm is one of the first Romanian producers of medicines and food supplements, with a tradition of over 100 years. Currently, Biofarm is one of the top 10 existing producers on the pharmaceutical market in Romania and has a product portfolio that covers 65 therapeutic areas.
Two Romanians were arrested during Sunday night, May 11, after robbing empty houses in the evacuated mountain village of Brienz located in the Swiss canton of Graubünden. The village had been evacuated since November due to rock falls. The locality was, however, monitored by the authorities to prevent break-ins. The would-be thieves apparently tried to […]
The European Bank for Reconstruction and Development, or EBRD, has revised its estimates regarding the evolution of the Romanian economy in 2025 downward to 1.6%. The bank expects Romania’s GDP to grow 0.2% less than the 1.8% estimate made in February, and to increase by 2.4% in 2026. Romania's GDP growth slowed to 0.8% in […]
During a meeting on Monday, May 12, the Cluj-Napoca Local Council approved a draft resolution that imposes smoking restrictions in several public spaces in the city, including public transport stations, parks, and sports facilities. The resolution was adopted with 22 votes in favor and 3 abstentions, and will come into effect 90 days from the […]
An internal survey by Romanian Business Leaders, which does not have national representativeness but was answered by 417 entrepreneurs, shows that 62% of entrepreneurs expect to have to make layoffs, while a third expect the number of employees to remain the same. The expected layoffs are directly connected to the possibility of Romania choosing a […]
Romanian Istvan Kovacs will be the main referee for the UEFA Champions League final between Paris St-Germain and Inter Milan, which will be played on May 31 in Munich. The match will be Kovacs’ third European final in the last 4 years. The 40-year-old referee has previously officiated the UEFA Europa Conference League final in […]
Over 70 museums across Romania will open their doors after hours for the 21st edition of Night of Museums, one of the country's most anticipated cultural events. Held on the night of May 17, the event offers visitors a unique opportunity to explore exhibitions, installations, and creative activities in an unconventional, late-night setting. From major […]
